David Shaw’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
David Shaw's ABCL Position: Q3 2026 in Review
David Shaw increased its AbCellera Biologics (ABCL) stake by 7,953% in Q3 2026, buying an estimated $34.3M and bringing the position to 3,658,344 shares worth $53.4M. The position accounts for 0.03% of the portfolio, ranked #724.
David Shaw first reported a position in ABCL in Q3 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- David Shaw held 3,658,344 shares of AbCellera Biologics worth $53.4M as of Q3 2026.
- David Shaw bought 3,612,913 AbCellera Biologics shares in Q3 2026, an estimated $34.3M.
- AbCellera Biologics made up 0.03% of David Shaw's portfolio in Q3 2026, its #724 holding.
- David Shaw first reported a position in AbCellera Biologics in Q3 2021 and has held it in 18 quarters since.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.